AzTrials
AzTrials

Parkinson's DiseaseNCT07772622

The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's Disease

An observational study of Parkinson's Disease and Validity, run by Sanko University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital. Patients who meet the inclusion criteria will be evaluated by Dr. Read more about this study

Who is it for?
Ages 40 to 65 years
Conditions the study is for
Parkinson's Disease, Validity, Reability
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Aug 2025to 25 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: parkinson

Inclusion Criteria:Individuals aged between 18 and 65 years who have been diagnosed with Parkinson's disease

Individuals who voluntarily agree to participate in the study -

Exclusion Criteria:Individuals who are pregnant or within the first three months postpartum

Individuals who have taken any medication affecting walking ability within the last month or who have experienced an orthopedic injury within the last month

-

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sanko Unıversıty

    Gaziantep, Gaziantep, 27090

Other trials in Turkey (Türkiye)

About this study

The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital.

Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University.

Read more

The assessment form prepared by the researchers will be completed face-to-face with the patients. First, demographic information and disease-related data (duration since Parkinson's diagnosis, disease stage, affected side, etc.) will be recorded. The Mini-BESTest will be used to evaluate balance and gait. The muscle strength of the ankle plantar flexor and dorsiflexor muscles will be assessed using a manual muscle testing device, and quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).

Since fall problems in patients may be related to balance impairments, lower limb muscle weakness, and reduced quality of life, these parameters will also be evaluated. Therefore, in this study, while examining the validity and reliability of the modified paper grip test in individuals with Parkinson's disease, its correlation with these parameters will also be investigated.

Before administering the tests, participants will receive a practical explanation of how the tests are performed and will be allowed to rest prior to assessment. The tests will be administered in the following order: first, the paper grip test by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle plantar and dorsiflexor muscle strength, and evaluation of quality of life.

One week after the initial assessment, only the paper grip test will be re-administered by Physiotherapist Fatma Yılmaz in the same environment. This approach will minimize the effect of environmental factors on the patients' performance.

Read the detailed description

Parkinson's disease is one of the most significant neurodegenerative disorders causing disability worldwide. It is characterized by progressive loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms such as bradykinesia, rigidity, tremor, postural instability, and gait disturbances. Symptoms vary depending on disease stage and the affected neural pathways. Common symptoms observed in individuals with Parkinson's disease include muscle weakness, reduced upper limb function, gait difficulties, balance and coordination impairments, and, in some cases, cognitive and communication problems.

Patients with Parkinson's disease are at high risk of falling, particularly due to balance and postural instability. Consequently, fear of falling can lead to kinesiophobia (fear of movement), decreased engagement in activities of daily living, and difficulties in functional adaptation. Balance problems are among the primary motor deficits in Parkinson's disease and contribute significantly to gait disturbances, postural instability, and fall risk. Therefore, balance rehabilitation is a key focus in the management of Parkinson's disease, especially for fall prevention.

A detailed assessment of balance is essential for planning effective rehabilitation programs. According to the literature, balance evaluation in Parkinson's patients is generally performed using static and dynamic assessments. Commonly used tools include the Mini-BESTest, the Functional Reach Test, and the Timed Up and Go Test (TUG). However, a major contributor to balance problems is lower extremity muscle weakness, particularly in the ankle. While research shows a significant relationship between lower limb muscle weakness and increased fall risk in Parkinson's patients, existing assessment tools often lack direct quantitative measurements, which may reduce their clinical effectiveness.

The Enhanced Paper Grip Test (EPGT) can help address this gap. The EPGT provides a simple measurement of hallux plantar flexion strength without requiring specialized equipment. It can be used to assess fall risk in individuals with Parkinson's disease and has been suggested as a practical screening tool in geriatric populations. The validity and reliability of the test have also been demonstrated in individuals diagnosed with multiple sclerosis. The EPGT is easy to administer, requires minimal space, is low-cost, and quick to perform, making it a practical clinical tool. In this study, the researchers aimed to examine the validity and reliability of the modified paper grip test in Parkinson's patients.

Volunteer patients diagnosed with Parkinson's disease who applied to the SANKO University Sani Konukoğlu Application and Research Hospital Neurology Polyclinic will be included in the study. Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University. The role of Associate Professor Zekiye İpek Kırmacı in the study includes planning the study, formulating hypotheses, interpreting the results, and preparing the manuscript for publication.

The assessment form prepared by the researchers will be completed face-to-face with patients. First, demographic information and disease-related data (such as disease duration, affected side, and affected limb) will be recorded. Balance and gait will be assessed using the Mini-BESTest. The muscle strength of the ankle plantar and dorsiflexor muscles will be measured using a manual muscle testing device, and quality of life will be evaluated with the Parkinson's Disease Questionnaire-39 (PDQ-39).

Because fall risk in Parkinson's patients may be related to balance impairments, lower limb muscle weakness, particularly in the ankle, and reduced quality of life, these parameters will also be examined. Therefore, in this study, while evaluating the validity and reliability of the modified paper grip test in Parkinson's patients, its correlation with these parameters will also be investigated.

Before administering the tests, participants will receive a practical explanation of the procedures and will be allowed to rest prior to assessment. The order of testing will be as follows: first, the paper grip test performed by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle muscle strength, and evaluation of quality of life.

Keywords
parkinson's disease, balance, validity, reability
Medical subject headings
Parkinson Disease

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mini best test

    1. Mini Best Test Description: This is one of the clinical tests used to assess walking and balance. It consists of four sub-parameters: preparatory movement, reactive postural control, sensory orientation, and dynamic walking, comprising a total of 14 items. It is a test scored out of a total of 28 points, taking an average of 10-15 minutes to complete. A high score indicates high function.

    Measured: Measured once, at baseline (Session 1)

  2. Manual muscle testing device

    1. Manual muscle testing device Description: muscle strength (right foot dorsiflexion, left foot dorsiflexion, right foot plantar flexion, left foot plantar flexion) will be measured using the Commander Echo brand manual muscle testing device. The participant will be a

    Measured: Measured once, at baseline (Session 1)

  3. Enhanced Paper Grasping Test

    Description: During measurement, participants will sit in a calm environment on a chair without armrests, with their feet and knees at a 90-degree angle, and their upper limbs comfortably placed alongside their torso. This test involves

    Measured: Baseline (Session 1) and 1 week later (Session 2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start10 Aug 2025
  3. Primary completion12 Jan 2026
  4. Study completion25 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07772622
Sponsor's protocol ID
hakanpolat15
Status last verified
Feb 2026
First submitted
25 Feb 2026
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Parkinson's Disease and Validity, run by Sanko University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mini best test (time frame: Measured once, at baseline (Session 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in